NEW YORK (GenomeWeb) – Ambry Genetics announced this week that it has opened its AmbryShare data sharing program to the public. AmbryShare contains data on more than 1 million variants from 11,400 hereditary breast and ovarian cancer patients. It is comprised of de-identified aggregated allele frequency data that includes analysis of all genes in the human genome. The company is also soliciting collaborations with interested researchers for new AmbryShare exome projects on autism and prostate cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.